HIV 1 News and Research

RSS

New 3D brain organoid may hold potential in drug discovery, disease modeling

Wake Forest Institute for Regenerative Medicine scientists have developed a 3D brain organoid that could have potential applications in drug discovery and disease modeling.

30 May 2018

UAB professor receives award for malaria prevention study in pregnant women in Cameroon

Jodie Dionne-Odom, M.D., assistant professor in the University of Alabama at Birmingham's Division of Infectious Diseases and chief of Women's Health Services at UAB's 1917 Clinic, has been awarded a five-year, $841,000 K23 grant from the National Institute of Child Health and Human Development of the National Institutes of Health.

25 May 2018

New study unravels secrets of HIV's persistence

Thanks to advances in the development of anti-retroviral therapy (ART), patients with HIV are living longer than ever before. And yet, even in patients on very effective, long-term ART, HIV persists, requiring patients to take antiviral medication life-long.

23 May 2018

Study: Many gay and bisexual teenage boys use adult hookup apps to connect with friends, partners

Although hookup apps require users to be 18 or older, a new Northwestern Medicine study found that more than 50 percent of sexually active gay and bisexual boys ages 14 to 17 met male sexual partners on apps such as Grindr and Scruff.

18 May 2018

Natural antioxidant bilirubin may provide cardiovascular benefits

Bilirubin, a yellow-orange pigment, is formed after the breakdown of red blood cells and is eliminated by the liver. It's not only a sign of a bruise, it may provide cardiovascular benefits, according to a large-scale epidemiology study.

18 May 2018

New CRISPR/Cas9 system targets regulatory genes of AIDS virus

By destroying the regulatory genes of the AIDS virus HIV-1 using the genome editing system CRISPR/Cas9, a Japanese research group has succeeded in blocking the production of HIV-1 by infected cells.

18 May 2018

HIV patients on single-tablet regimen show better outcomes than those taking multiple pills

HIV patients on a single-tablet daily regimen had better treatment retention and viral suppression than patients taking multiple pills, in a study by a Michael E. DeBakey Veterans Affairs Medical Center researcher and his colleagues.

18 May 2018

Experts available to discuss subjects related to Ebola virus

Georgetown University Medical Center (GUMC) professors offer expertise for journalists seeking interviews in a variety of subjects related to Ebola.

18 May 2018

Study: Social connections may protect black men who have sex with men from acquiring HIV

UCLA-led research suggests that receiving support from friends and acquaintances can help prevent black men who have sex with men from becoming infected with HIV.

17 May 2018

California’s deadly STD epidemic sets record

Diagnoses of sexually transmitted diseases hit a record high in California last year — with sometimes deadly consequences, according to preliminary state data released this week.

17 May 2018

Study finds distinct exhausted T cells that could have implications for fighting different diseases

The battle between the human immune system and long-term, persisting infections and other chronic diseases such as cancer results in a prolonged stalemate

16 May 2018

First epoetin alfa biosimilar receives FDA approval to treat certain types of anemia

The U.S. Food and Drug Administration today approved Retacrit (epoetin alfa-epbx) as a biosimilar to Epogen/Procrit (epoetin alfa) for the treatment of anemia caused by chronic kidney disease, chemotherapy, or use of zidovudine in patients with HIV infection.

16 May 2018

Scientists discover a mechanism through which HIV determines the fate and function of cells

A stem cell is one with infinite possibilities. So, for decades, scientists have puzzled over how the cell chooses to keep being a stem cell and continue dividing, or specialize into a specific cell type, like a heart or brain cell.

11 May 2018

New studies use proteomics to shed light on pathogenic mechanisms

Recent studies in the journal Molecular & Cellular Proteomics have shed light on pathogenic mechanisms of the sexually-transmitted parasite Trichomonas vaginalis and the HIV-associated opportunistic lung fungus Aspergillus.

11 May 2018

Study examines social perceptions of HIV-prevention drug among gay and bisexual men

A new study led by a UTSA researcher examines the social perceptions of Pre-Exposure Prophylaxis (PrEP), a medication to prevent HIV, among gay and bisexual men in Texas.

9 May 2018

Research findings could lead to new therapies to curb ovarian cancer metastasis

In order to spread their destruction, ovarian cancer cells must break free from their tumor home, travel through the fluid in the peritoneal cavity and attach to the outside of the abdominal organs--surfaces that are, by necessity, not sticky.

9 May 2018

Stimulant use may negatively affect health of HIV-positive persons

A researcher at the University of Miami Miller School of Medicine has found that the use of stimulants, such as methamphetamine, can negatively affect the health of HIV-positive persons even when they are adhering to medical treatment.

4 May 2018

Unexpected discovery could improve detection of malaria infections

While the global health community has made great strides toward eradicating malaria through prevention and treatment strategies, rapid and inexpensive methods to diagnose submicroscopic malaria in individuals who have no clinical symptoms and undetectable levels of disease-causing parasites in their blood remain an unmet need.

4 May 2018

New survey highlights need for BV awareness and education to ensure proper care

Lupin Pharmaceuticals Inc., the U.S. wholly owned subsidiary of Lupin Limited, dedicated to delivering high-quality medications trusted by healthcare professionals and women across many treatment areas, has partnered with the National Association of Nurse Practitioners in Women's Health to conduct a national online survey of 301 HCPs (including OB/GYNs and NP/PAs) who treat women with bacterial vaginosis (BV).

4 May 2018

Study underlines importance of early HIV treatment to avoid brain atrophy

While the human immunodeficiency virus (HIV) has largely dropped from news headlines since the 1990s, at the end of 2016 there were 36.7 million people living with the infection, and of those only 53 per cent had access to treatment.

3 May 2018

HIV 1 News and Research

New 3D brain organoid may hold potential in drug discovery, disease modeling

UAB professor receives award for malaria prevention study in pregnant women in Cameroon

New study unravels secrets of HIV's persistence

Study: Many gay and bisexual teenage boys use adult hookup apps to connect with friends, partners

Natural antioxidant bilirubin may provide cardiovascular benefits

New CRISPR/Cas9 system targets regulatory genes of AIDS virus

HIV patients on single-tablet regimen show better outcomes than those taking multiple pills

Experts available to discuss subjects related to Ebola virus

Study: Social connections may protect black men who have sex with men from acquiring HIV

California’s deadly STD epidemic sets record

Study finds distinct exhausted T cells that could have implications for fighting different diseases

First epoetin alfa biosimilar receives FDA approval to treat certain types of anemia

Scientists discover a mechanism through which HIV determines the fate and function of cells

New studies use proteomics to shed light on pathogenic mechanisms

Study examines social perceptions of HIV-prevention drug among gay and bisexual men

Research findings could lead to new therapies to curb ovarian cancer metastasis

Stimulant use may negatively affect health of HIV-positive persons

Unexpected discovery could improve detection of malaria infections

New survey highlights need for BV awareness and education to ensure proper care

Study underlines importance of early HIV treatment to avoid brain atrophy

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News